http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1248893-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-16
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-16
filingDate 1986-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dcdcbc2eb4fa51911187b069dd1bd35
publicationDate 1989-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1248893-A
titleOfInvention Murine hybridoma lym-1 and diagnostic antibody produced thereby
abstract ABSTRACT Hybridoma Lym-1 (ATCC No. HB 8612) produces murine IgG2a monoclonal antibodies specifically against normal human B cells and derived malignancies. The Lym-1 antibodies have clinical utility for the in vivo diagnosis and therapy of human B-cell lymphomas and leukemias.
priorityDate 1985-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9N2D4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449106702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28713
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420473686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490851
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450455866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID173553
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8060
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27822
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450183611
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11489
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02879
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00793
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8060
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81497
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13636
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00792
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415723855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453280128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554661

Total number of triples: 54.